Lana E. Kandalaft

Best Publications

• Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

  Denarda Dangaj;Marine Bruand;Alizée J. Grimm;Catherine Ronet

  844
  Citations

• Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

  Janos L. Tanyi;Sara Bobisse;Eran Ophir;Sandra Tuyaerts

  427
  Citations

• Whole Tumor Antigen Vaccines: Where Are We?

  Cheryl Lai-Lai Chiang;George Coukos;George Coukos;Lana E. Kandalaft;Lana E. Kandalaft

  339
  Citations

• T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

  Natalie J. Neubert;Martina Schmittnaegel;Natacha Bordry;Sina Nassiri

  295
  Citations

• Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.

  Michal Bassani-Sternberg;Chloé Chong;Chloé Chong;Philippe Guillaume;Philippe Guillaume;Marthe Solleder;Marthe Solleder

  285
  Citations

• Antitumour dendritic cell vaccination in a priming and boosting approach

  Alexandre Harari;Alexandre Harari;Michele Graciotti;Michele Graciotti;Michal Bassani-Sternberg;Michal Bassani-Sternberg;Lana E Kandalaft;Lana E Kandalaft

  252
  Citations

• Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

  U Dafni;U Dafni;O Michielin;S Martin Lluesma;S Martin Lluesma;Z Tsourti

  241
  Citations

• A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

  Cheryl Lai-Lai Chiang;Lana E. Kandalaft;Janos Tanyi;Andrea R. Hagemann

  237
  Citations

• Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

  Beatris Mastelic-Gavillet;Blanca Navarro Rodrigo;Laure Décombaz;Haiping Wang

  204
  Citations

• Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

  Unknown

  201
  Citations

• Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation

  Unknown

  200
  Citations

• Immunotherapy for Ovarian Cancer: What's Next?

  Lana E. Kandalaft;Daniel J. Powell;Nathan Singh;George Coukos

  189
  Citations

• The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

  Kalijn F. Bol;Gerty Schreibelt;Katrin Rabold;Stefanie K. Wculek

  179
  Citations

• Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

  Lana E. Kandalaft;Daniel J. Powell;Cheryl L. Chiang;Janos Tanyi

  179
  Citations

• Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.

  Jaikumar Duraiswamy;Riccardo Turrini;Aspram Minasyan;David Barras

  179
  Citations

• Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.

  Sara Bobisse;Raphael Genolet;Annalisa Roberti;Janos L. Tanyi

  160
  Citations

• Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ.

  Markus Germann;Nadine Zangger;Nadine Zangger;Nadine Zangger;Marc-Olivier Sauvain;Christine Sempoux

  157
  Citations

• A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.

  Lana E Kandalaft;Daniel J Powell;George Coukos

  156
  Citations

• Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines

  Cheryl Lai-Lai Chiang;Lana E. Kandalaft;George Coukos

  146
  Citations

• Rational combinations of immunotherapy with radiotherapy in ovarian cancer

  Fernanda G Herrera;Fernanda G Herrera;Melita Irving;Lana E Kandalaft;Lana E Kandalaft;George Coukos;George Coukos

  136
  Citations